The GRN gene gives your body instructions to make progranulin, a protein that helps brain cells and immune cells stay healthy, and low levels can lead to certain brain conditions. This gene helps your body control inflammation and recycle worn out cell material so cells keep working smoothly. Pathogenic variants in the GRN gene are linked to some cases of frontotemporal dementia, and having two nonworking copies can cause a rare childhood condition that affects the brain and other parts of the body.
What is a gene?
A gene is a stretch of DNA that holds instructions your cells use to make molecules or regulate activities in the body. Some genes carry the directions for producing proteins, the parts of cells that do the work. Others mainly guide when certain activities happen, where they take place, and how strongly they occur. Together, genes affect how the body develops and works, and they can influence how you respond to food, stress, or medications. More on this topic is available in the LearnHub.
Overview
GRNGene function
What if the gene works
The GRN gene helps your body make progranulin, a protein that supports brain cells and helps control inflammation. It also helps lysosomes, the cell’s recycling centers, work properly.
Risk
What if the gene does not work
Variants in the GRN gene can lower progranulin levels. Milder to more severe variants may affect age at onset and features. One nonworking copy is linked to adult-onset frontotemporal dementia, while two can cause childhood neuronal ceroid lipofuscinosis.
Treatment
What does that mean for your treatment
For pathogenic variants in the GRN gene, no GRN specific treatment or management approach is currently established in clinical guidelines. The GRN gene is being studied as a drug target, and treatments that aim to raise progranulin levels, including gene therapy and antibody based approaches, are under study for frontotemporal dementia.
Conditions associated with GRN
Gene function
What if the gene works
Your cells need the GRN gene for steady cleanup and balanced signaling. It helps make progranulin, a protein used in many tissues, especially the brain and immune system. When the GRN gene is active, cells can recycle worn out material and keep inflammatory signals more controlled.
GRN helps supply progranulin to lysosomes (the cell compartments that break down and reuse old material). This everyday recycling role is a central part of what the GRN gene does in the body.
Progranulin helps tune immune signals so inflammation stays more balanced. This helps tissues, including the brain, keep a steadier environment for normal cell function.
Cells can release progranulin as a messenger protein that supports growth, survival, and routine repair. This is useful in tissues that face everyday wear and need steady renewal.
What is a variant?
A genetic variant is a minor change in a gene’s DNA sequence. Variants are common and are part of normal human diversity, including differences in appearance, metabolism, and the way the body reacts to environmental influences. Many do not cause any noticeable effects and simply represent natural genetic variation. At times, though, a variant can change how a gene works more significantly and may contribute to, or cause, a genetic condition.
Genetic variants
What if the gene does not work
Variants in the GRN gene often reduce progranulin production or create an unstable protein that is broken down early. This is how GRN gene variants affect protein function: milder changes may leave some activity, while more severe variants can leave cells with very little working protein and disrupt lysosomes (the cell's recycling centers). This reduced function is linked to frontotemporal dementia, and two severe variants can be associated with a brain condition that begins in childhood.
How variants are linked to conditions
Pathogenic variants in the GRN gene can cause frontotemporal dementia, and the link between GRN gene variants and frontotemporal dementia is well established in clinical genetics. This condition may affect behavior, personality, or language. More rarely, severe variants in both copies of the GRN gene can lead to neuronal ceroid lipofuscinosis type 11, a childhood-onset neurologic condition.
A variant is not necessarily a diagnosis
Variants in genes are common in the general population and are a normal feature of human biology. Most do not have a direct effect on health and simply reflect natural human diversity. For many genes, carrying a variant associated with a condition indicates a possible link rather than a definite diagnosis, especially when several genes and environmental factors contribute. In some situations, though, a single well-characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For GRN, risk is usually driven mainly by the specific inherited gene change, especially for forms linked to frontotemporal dementia. Age can also matter, since symptoms often appear in adulthood, but there is not enough evidence to say that lifestyle changes clearly lower or raise GRN-related risk.
Inheritance of GRN variants
How GRN gene variants are inherited depends on the condition involved. For frontotemporal dementia linked to the GRN gene, the usual pattern is autosomal dominant, which means a parent carrying the variant can pass it to each child with a 50% chance. A different GRN-related condition, neuronal ceroid lipofuscinosis, follows an autosomal recessive pattern, so it usually happens when a person inherits one altered copy from each parent.
What does my GRN result mean for my family?
A GRN result can mean different things for relatives, depending on which GRN-related condition is involved. For the more common adult-onset brain condition linked to one changed copy, close family members such as parents, brothers, sisters, and children may also carry the variant and may wish to discuss testing. GRN can also cause a separate, rarer condition when both copies are changed, which means relatives may be healthy carriers.
Genetic information
Genetic testing
How you find out about variants
To look for changes in the GRN gene, doctors use genetic testing for GRN variants on a blood or saliva sample. A lab reads the DNA sequence and checks for missing or extra pieces, then reports whether a variant linked to frontotemporal dementia is found, not found, or remains uncertain.
When should I consider getting a genetic test?
Genetic testing for the GRN gene may be worth considering if you or close relatives have frontotemporal dementia, especially with symptoms starting at a younger age or a strong family history. This condition often shows up as big changes in behavior, personality, or language, and testing can help clarify whether an inherited gene change is involved.
A genetic result is only one part of your health story
A genetic result can provide useful insight, but how much it explains depends on the condition and the kind of variant involved. How the body works over time is also shaped by many factors, including lifestyle, environment, age, and medical history. For some conditions, especially those influenced by many genes, genetic information offers context rather than certainty and is best understood together with other parts of care. In other situations, a genetic result may give a clear answer. In areas like medication response, genetic results can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in DNA can change how the body breaks down a drug, moves it through the bloodstream, or responds to it at its target. This helps explain why the same treatment works well for one person, works less well for another, or causes more side effects in someone who is more sensitive to it.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences can affect the way people respond to medications. By studying links between genes and drugs, it helps explain why the same treatment may work differently in different people. With many medicines, genes can influence both how the body handles a drug and how strong its effects are. This information can support treatment choices that are more informed and more tailored to the individual. To look into this subject more closely, you can learn more in the LearnHub.
Drugs influenced by the GRN gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in predicting how medicines will work or what side effects they may cause. If you have concerns about a treatment, unexpected side effects, or changes in your medicines, talk with your doctor or pharmacist.
History
The GRN gene entered a new phase of recognition in the 1990s, when researchers described progranulin as a protein involved in cell growth and repair. From these first observations, research expanded steadily. A major turning point came in 2006, when pathogenic variants in the GRN gene were identified as a cause of inherited frontotemporal dementia, helping explain why some families developed changes in behavior, language, or thinking across generations. That discovery quickly made the GRN gene an important part of dementia genetics. A few years later, scientists also linked having pathogenic variants in both copies of the GRN gene to a rare childhood lysosomal condition called neuronal ceroid lipofuscinosis. These findings established the GRN gene as relevant in both adult and childhood neurologic disease.